ArticleBritish journal of pharmacology2020

Icariside II, a phosphodiesterase 5 inhibitor, attenuates cerebral ischaemia/reperfusion injury by inhibiting glycogen synthase kinase-3β-mediated activation of autophagy.

Jianmei Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.